• Wion
  • /World
  • /Bharat Biotech announces successful Phase-3 trial results of Covaxin

Bharat Biotech announces successful Phase-3 trial results of Covaxin

Bharat Biotech has announced the Phase 3 clinical trial results for its Coronavirus vaccine candidate Covaxin. The company said that Covaxin demonstrated an efficacy of 81 per cent in the trials.